- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Hospira Inc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Hospira Inc in the form of a SWOT analysis
An in-depth view of the business model of Hospira Inc including a breakdown and examination of key business segments
Intelligence on Hospira Inc’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Hospira Inc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Hospira (or 'the company') is a leading provider of injectable drugs and infusion technologies. It develops, manufactures and markets products including generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems. The company operates in the Americas, Europe, Middle East, Africa and Asia-Pacific regions. It is headquartered in Lake Forest, Illinois, and employed about 17,000 people as on December 31, 2013. The company recorded revenues of $4,002.8 million during the financial year ended December 2013 (FY2013), a decrease of 2.2% over FY2012. The operating profit of the company was $16.6 million in FY2013, a decrease of 71.8% over FY2012. The net loss of the company was $8.3 million in FY2013, as compared to a net profit of $44.2 million in FY2012.
Reasons to Purchase:
Gain understanding of Hospira Inc and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Hospira Inc as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Hospira Inc’s business structure, strategy and prospects